General Updates

Date: 18th July, 2026 To, To, The Manager (Listing) Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, G Block, Dalal Street, Fort, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 506260 NSE Symbol: ANUHPHR; Series: EQ Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 read with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has dispatched letters to those Shareholders whose e-mail addresses are not registered with the Company, its Registrar and Share Transfer Agent ("RTA"), or their respective Depository Participant(s). The said communication provides the web link and the navigation path for accesing the Annual Report for the Financial Year 2025-26 on the Company’s website. A copy of the communication sent to the concerned shareholders is enclosed herewith for your information and records. Kindly take the above information on record. Thanking you, Yours faithfully, FOR ANUH PHARMA LIMITED MANAN VADHAN COMPANY SECRETARY & COMPLIANCE OFFICER Encl: As above To, Date: 18th July, 2026 The Shareholder(s) Subject: Intimation of the 66th Annual General Meeting and availability of Annual Report for the Financial Year 2025-26. Dear Shareholder, We are pleased to inform you that the 66th Annual General Meeting (“AGM”) of Anuh Pharma Limited (“the Company”) is scheduled to be held on Wednesday, 12th August, 2026 at 04:00 p.m. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”), to transact the business as set out in the AGM Notice. The Notice of the 66th AGM together with the Annual Report for the financial year 2025-26 is being sent by electronic mode only to those Members whose e-mail addresses are registered with the Company, its Registrar and Share Transfer Agent (“RTA”) or their respective Depository Participant(s) (“DPs”). In accordance with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, this communication is being sent to you as your e-mail address is not registered with the Company RTA / or your Depository Participant. Accordingly, the web-link and navigation path for accessing the Annual Report of Company are provided below: Weblink: https://www.anuhpharma.com/investor-relations/wp-content/uploads/2026/07/APL_AR- 2025-26_Final.pdf Website Navigation Path: www.anuhpharma.com > Investor Relations > Annual Reports > Financial Year 2025 - 2026 The Company encourages its Members to register or update their email IDs with the Depository Participants/ Bigshare Services Pvt Ltd by mailing at investor@bigshareonline.com, to receive all communications electronically. Members holding shares in physical form are requested to consider dematerializing their holdings to ensure compliance with SEBI guidelines and to facilitate faster and safer transactions. We thank you for your continued trust and support and look forward to your participation at the 66th AGM. Warm regards, FOR ANUH PHARMA LIMITED Sd/- MANAN VADHAN COMPANY SECRETARY AND COMPLIANCE OFFICER